BPG is committed to discovery and dissemination of knowledge
Articles in Press
2/12/2026 8:33:22 AM | Browse: 4 | Download: 0
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Minireviews |
| Article Title |
Incretin polyagonists as an alternative to bariatric surgery to manage obesity
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Rohit Jacob Manoj, Cornelius J Fernandez, Sunil Nair and Joseph M Pappachan |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Joseph M Pappachan, FRCP, MD, MRCP, Professor, Senior Researcher, Faculty of Science, Manchester Metropolitan University, Oxford Road, Manchester M15 6BH, Greater Manchester, United Kingdom. drpappachan@yahoo.co.in |
| Key Words |
Incretin polyagonists; Obesity; Bariatric surgery; Weight loss; Metabolic health; Tirzepatide; Type 2 diabetes mellitus |
| Core Tip |
Incretins are gut hormones involved in metabolic homeostasis of human body and disorders of the incretin system is recognized as the main reason for the pathobiology of metabolic dysfunction and obesity. Incretin polyagonists are transforming the landscape of obesity treatment by offering potent, non-surgical alternatives to bariatric procedures with remarkable improvements in complications of adiposity including type 2 diabetes and metabolic dysfunction-associated fatty liver disease. Recent clinical trials demonstrate that dual and triple agonists can produce weight reductions comparable to, or in some cases approaching, those seen with bariatric surgery, while simultaneously improving glycemic control, lipid profiles, liver fat, and cardiovascular risk factors. This review discusses the current evidence base for optimal use of incretin polyagonists as an alternative to bariatric surgery. |
| Citation |
Manoj RJ, Fernandez CJ, Nair S, Pappachan JM. Incretin polyagonists as an alternative to bariatric surgery to manage obesity. World J Gastrointest Pathophysiol 2026; In press |
 |
Received |
|
2025-12-24 03:30 |
 |
Peer-Review Started |
|
2025-12-24 03:30 |
 |
First Decision by Editorial Office Director |
|
2026-01-07 02:38 |
 |
Return for Revision |
|
2026-01-07 02:38 |
 |
Revised |
|
2026-01-10 19:18 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2026-02-12 02:41 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-02-12 08:33 |
 |
Articles in Press |
|
2026-02-12 08:33 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
2150-5330 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345